ANGELA GARLAND: Open Payments
NPI 1124634605 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,226 in 58 payments from 13 companies in 2025. Trend: 2023 $588 · 2024 $1,180 · 2025 $1,226
Food & beverage: $1,226
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $233 |
| Antares Pharma, Inc. | 9 | $214 |
| Axsome Therapeutics, Inc. | 4 | $165 |
| ABBVIE INC. | 15 | $164 |
| Lilly USA, LLC | 2 | $117 |
| Vanda Pharmaceuticals Inc. | 3 | $63 |
| Exact Sciences Corporation | 3 | $62 |
| Novo Nordisk Inc | 3 | $60 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $57 |
| GlaxoSmithKline, LLC. | 2 | $35 |
Products named: XYOSTED, Auvelity, AIRSUPRA, VRAYLAR, ZEPBOUND, HETLIOZ, The Cologuard Plus Collection Kit, BREZTRI.
Industry payments across OH — which companies pay providers there.
